Furthermore, the pSS patients were categorized in subgroups based on clinical parameters including SSA and/or SSB autoantibody positivity and focus score to verify whether there was any relation between disease features and mRNA expression levels. The gene discussed is CALR; the disease is peeling skin syndrome.